EAM
CYTK icon

Exome Asset Management’s Cytokinetics CYTK Stock Holding History

Exome Asset Management’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.84M Sell
103,718
-21,031
-17% -$1.34M 4.02% 7
2025
Q4 		$7.93M Sell
124,749
-17,668
-12% -$1.1M 3.92% 6
2025
Q3 		$7.83M Buy
142,417
+26,600
+23% +$1.1M 5.17% 2
2025
Q2 		$3.83M Buy
115,817
+12,334
+12% +$429K 3.47% 9
2025
Q1 		$4.16M Buy
103,483
+37,600
+57% +$1.73M 3.73% 5
2024
Q4 		$3.1M Buy
65,883
+7,300
+12% +$379K 2.33% 19
2024
Q3 		$3.09M Buy
+58,583
New +$3.27M 2.09% 19
2024
Q2 		– Sell
-26,008
Closed -$1.82M – 58
2024
Q1 		$1.82M Sell
26,008
-8,900
-25% -$688K 1.56% 25
2023
Q4 		$2.91M Buy
+34,908
New +$1.26M 2.88% 11

Other funds holding CYTK

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return